Annual Total Debt
$1.51 B
+$6.55 M+0.44%
December 31, 2024
Summary
- As of February 26, 2025, HALO annual total debt is $1.51 billion, with the most recent change of +$6.55 million (+0.44%) on December 31, 2024.
- During the last 3 years, HALO annual total debt has risen by +$629.12 million (+71.76%).
- HALO annual total debt is now -0.02% below its all-time high of $1.51 billion, reached on December 31, 2022.
Performance
HALO Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.51 B
+$1.64 M+0.11%
December 31, 2024
Summary
- As of February 26, 2025, HALO quarterly total debt is $1.51 billion, with the most recent change of +$1.64 million (+0.11%) on December 31, 2024.
- Over the past year, HALO quarterly total debt has increased by +$6.55 million (+0.44%).
- HALO quarterly total debt is now -0.02% below its all-time high of $1.51 billion, reached on December 31, 2022.
Performance
HALO Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
HALO Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.4% | +0.4% |
| 3 y3 years | +71.8% | +0.6% |
| 5 y5 years | +274.0% | +0.6% |
HALO Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.0% | +71.8% | -0.0% | +71.8% |
| 5 y | 5-year | -0.0% | +279.1% | -0.0% | +286.7% |
| alltime | all time | -0.0% | -100.0% | -0.0% | -100.0% |
Halozyme Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.51 B(+0.4%) | $1.51 B(+0.1%) |
| Sep 2024 | - | $1.50 B(+0.1%) |
| Jun 2024 | - | $1.50 B(+0.1%) |
| Mar 2024 | - | $1.50 B(+0.1%) |
| Dec 2023 | $1.50 B(-0.5%) | $1.50 B(+0.1%) |
| Sep 2023 | - | $1.50 B(+0.1%) |
| Jun 2023 | - | $1.50 B(+0.1%) |
| Mar 2023 | - | $1.49 B(-0.8%) |
| Dec 2022 | $1.51 B(+71.8%) | $1.51 B(+0.1%) |
| Sep 2022 | - | $1.50 B(+20.7%) |
| Jun 2022 | - | $1.25 B(+42.0%) |
| Mar 2022 | - | $877.64 M(+0.1%) |
| Dec 2021 | $876.67 M(+120.7%) | $876.67 M(+0.1%) |
| Sep 2021 | - | $875.71 M(+0.1%) |
| Jun 2021 | - | $874.74 M(+0.1%) |
| Mar 2021 | - | $873.77 M(+120.0%) |
| Dec 2020 | $397.23 M(-1.3%) | $397.23 M(+0.9%) |
| Sep 2020 | - | $393.63 M(+0.9%) |
| Jun 2020 | - | $390.08 M(+0.2%) |
| Mar 2020 | - | $389.43 M(-3.3%) |
| Dec 2019 | $402.59 M(+218.6%) | $402.59 M(+530.6%) |
| Sep 2019 | - | $63.84 M(-24.9%) |
| Jun 2019 | - | $84.96 M(-19.4%) |
| Mar 2019 | - | $105.41 M(-16.6%) |
| Dec 2018 | $126.38 M(-37.5%) | $126.38 M(-13.7%) |
| Sep 2018 | - | $146.46 M(-11.8%) |
| Jun 2018 | - | $166.04 M(-10.3%) |
| Mar 2018 | - | $185.16 M(-8.5%) |
| Dec 2017 | $202.35 M(-6.6%) | $202.35 M(-2.2%) |
| Sep 2017 | - | $206.85 M(-2.0%) |
| Jun 2017 | - | $211.03 M(-1.4%) |
| Mar 2017 | - | $214.03 M(-1.2%) |
| Dec 2016 | $216.62 M(+334.7%) | $216.62 M(+2.1%) |
| Sep 2016 | - | $212.20 M(+2.0%) |
| Jun 2016 | - | $208.14 M(+6.2%) |
| Mar 2016 | - | $196.02 M(+293.3%) |
| Dec 2015 | $49.83 M(-0.1%) | $49.83 M(+0.1%) |
| Sep 2015 | - | $49.79 M(+0.1%) |
| Jun 2015 | - | $49.75 M(+0.1%) |
| Mar 2015 | - | $49.72 M(-0.3%) |
| Dec 2014 | $49.86 M(+0.2%) | $49.86 M(+0.0%) |
| Sep 2014 | - | $49.84 M(+0.0%) |
| Jun 2014 | - | $49.82 M(+0.0%) |
| Mar 2014 | - | $49.79 M(+0.0%) |
| Dec 2013 | $49.77 M | $49.77 M(+54.1%) |
| Sep 2013 | - | $32.30 M(+1.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $31.82 M(+2.2%) |
| Mar 2013 | - | $31.14 M(+0.1%) |
| Dec 2012 | $31.11 M(>+9900.0%) | $31.11 M(>+9900.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2004 | - | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2003 | - | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2002 | - | $0.00(0.0%) |
| Jun 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00 |
| Dec 2001 | $0.00 | - |
FAQ
- What is Halozyme Therapeutics annual total debt?
- What is the all time high annual total debt for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual total debt year-on-year change?
- What is Halozyme Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly total debt year-on-year change?
What is Halozyme Therapeutics annual total debt?
The current annual total debt of HALO is $1.51 B
What is the all time high annual total debt for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual total debt is $1.51 B
What is Halozyme Therapeutics annual total debt year-on-year change?
Over the past year, HALO annual total debt has changed by +$6.55 M (+0.44%)
What is Halozyme Therapeutics quarterly total debt?
The current quarterly total debt of HALO is $1.51 B
What is the all time high quarterly total debt for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly total debt is $1.51 B
What is Halozyme Therapeutics quarterly total debt year-on-year change?
Over the past year, HALO quarterly total debt has changed by +$6.55 M (+0.44%)